高级检索
当前位置: 首页 > 详情页

A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the Fibrinogen/Albumin Ratio

文献详情

资源类型:
机构: [1]Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [2]Sun Yat Sen Univ, Canc Ctr, Dept Thorac Surg, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China; [3]Guangdong Esophageal Canc Inst, Guangzhou, Guangdong, Peoples R China; [4]Sun Yat Sen Univ, Affiliated Hosp 3, Dept Ultrasound, 600 Tianhe Rd, Guangzhou, Guangdong, Peoples R China; [5]Sun Yat Sen Univ, Affiliated Hosp 5, Dept Thorac Surg, Zhuhai, Peoples R China
出处:
ISSN:

关键词: esophageal squamous cell carcinoma blood tool fibrinogen albumin

摘要:
Background: Coagulation and nutrition play important roles in cancer progression. We aim to investigate the impact of the fibrinogen/albumin ratio(FAR) in esophageal squamous cell carcinoma (ESCC) patients. Methods: We retrospectively analyzed 1135 patients with radical esophagectomy for ESCC from January 2008 to December 2010 in our center. X-tile software was used to determine the optimal cutoff levels for these biomarkers. Results: The optimal cutoff value was 0.08 for the FAR by the X-tile software. The FAR was statistically significantly associated with age(p=0.003), sex(p=0.030), tumor length (p=0.043), pT status(p<0.001) and pN status(p<0.001). Pearson's correlation indicated that the FAR were positively associated with the serum C-reactive protein (CRP) (r=0.583, p<0.001), and the NLR ( r=0.316, p<0.001). Multivariate analysis indicated that age, tumor grade, pT status, pN status and preoperative FAR were independent prognostic factors in patients with ESCC. Conclusions: Preoperative FAR was an independent prognostic factor in ESCC patients. Lower FAR may improve OS of ESCC patients.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
第一作者:
第一作者机构: [1]Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [2]Sun Yat Sen Univ, Canc Ctr, Dept Thorac Surg, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China; [3]Guangdong Esophageal Canc Inst, Guangzhou, Guangdong, Peoples R China;
通讯作者:
通讯机构: [1]Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [2]Sun Yat Sen Univ, Canc Ctr, Dept Thorac Surg, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China; [3]Guangdong Esophageal Canc Inst, Guangzhou, Guangdong, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43370 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号